Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital
Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior exec
关键词:IPO · 综合
本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/6b3e51ca32a723be。